Talpa occidentalis (Iberian mole): 119257947
Help
Entry
119257947 CDS
T07495
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
tod
Talpa occidentalis (Iberian mole)
Pathway
tod01524
Platinum drug resistance
tod04010
MAPK signaling pathway
tod04115
p53 signaling pathway
tod04148
Efferocytosis
tod04210
Apoptosis
tod04215
Apoptosis - multiple species
tod04623
Cytosolic DNA-sensing pathway
tod04650
Natural killer cell mediated cytotoxicity
tod04657
IL-17 signaling pathway
tod04668
TNF signaling pathway
tod04726
Serotonergic synapse
tod04932
Non-alcoholic fatty liver disease
tod04933
AGE-RAGE signaling pathway in diabetic complications
tod04936
Alcoholic liver disease
tod05010
Alzheimer disease
tod05012
Parkinson disease
tod05014
Amyotrophic lateral sclerosis
tod05016
Huntington disease
tod05020
Prion disease
tod05022
Pathways of neurodegeneration - multiple diseases
tod05132
Salmonella infection
tod05133
Pertussis
tod05134
Legionellosis
tod05145
Toxoplasmosis
tod05146
Amoebiasis
tod05152
Tuberculosis
tod05160
Hepatitis C
tod05161
Hepatitis B
tod05162
Measles
tod05163
Human cytomegalovirus infection
tod05164
Influenza A
tod05165
Human papillomavirus infection
tod05167
Kaposi sarcoma-associated herpesvirus infection
tod05168
Herpes simplex virus 1 infection
tod05169
Epstein-Barr virus infection
tod05170
Human immunodeficiency virus 1 infection
tod05200
Pathways in cancer
tod05203
Viral carcinogenesis
tod05205
Proteoglycans in cancer
tod05206
MicroRNAs in cancer
tod05210
Colorectal cancer
tod05222
Small cell lung cancer
tod05416
Viral myocarditis
tod05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
tod00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
119257947 (CASP3)
04668 TNF signaling pathway
119257947 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
119257947 (CASP3)
09143 Cell growth and death
04210 Apoptosis
119257947 (CASP3)
04215 Apoptosis - multiple species
119257947 (CASP3)
04115 p53 signaling pathway
119257947 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
119257947 (CASP3)
04650 Natural killer cell mediated cytotoxicity
119257947 (CASP3)
04657 IL-17 signaling pathway
119257947 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
119257947 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
119257947 (CASP3)
05206 MicroRNAs in cancer
119257947 (CASP3)
05205 Proteoglycans in cancer
119257947 (CASP3)
05203 Viral carcinogenesis
119257947 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
119257947 (CASP3)
05222 Small cell lung cancer
119257947 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
119257947 (CASP3)
05161 Hepatitis B
119257947 (CASP3)
05160 Hepatitis C
119257947 (CASP3)
05164 Influenza A
119257947 (CASP3)
05162 Measles
119257947 (CASP3)
05168 Herpes simplex virus 1 infection
119257947 (CASP3)
05163 Human cytomegalovirus infection
119257947 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
119257947 (CASP3)
05169 Epstein-Barr virus infection
119257947 (CASP3)
05165 Human papillomavirus infection
119257947 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
119257947 (CASP3)
05133 Pertussis
119257947 (CASP3)
05134 Legionellosis
119257947 (CASP3)
05152 Tuberculosis
119257947 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
119257947 (CASP3)
05145 Toxoplasmosis
119257947 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
119257947 (CASP3)
05012 Parkinson disease
119257947 (CASP3)
05014 Amyotrophic lateral sclerosis
119257947 (CASP3)
05016 Huntington disease
119257947 (CASP3)
05020 Prion disease
119257947 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
119257947 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
119257947 (CASP3)
05416 Viral myocarditis
119257947 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
119257947 (CASP3)
04932 Non-alcoholic fatty liver disease
119257947 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
119257947 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
119257947 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
tod01002
]
119257947 (CASP3)
Enzymes [BR:
tod01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
119257947 (CASP3)
Peptidases and inhibitors [BR:
tod01002
]
Cysteine peptidases
Family C14: caspase family
119257947 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
119257947
NCBI-ProteinID:
XP_037382298
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MEYSENSVDSKSIKNSEMKIFHGSKSMDSGISLDNSYKMDYPEMGLCVIINNKNFLGSTG
MACRSGTDEDAAKLRETFLNLKYEVQNKNDLTCKEIKELMYDVSKEDHSKRSSFVCVLLS
HGDEGIIYGTDGPIDLKILTGYFKGENCRSLTGKPKLFIIQACRGTDLDSGIETDSGTDD
DMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLYAHKLELMHILTRVN
QKVAREYESFSLNSTFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagtactctgaaaactcagtggattcaaaatccattaaaaattcagaaatgaagatc
ttccatggaagcaaatcaatggactctgggatatccttggacaatagttacaaaatggat
tatcctgaaatgggtttatgtgtaataattaataataagaactttcttgggagtactgga
atggcatgtcggtctggtacagatgaagatgcagcaaagctcagggaaacattcctgaac
ttgaaatatgaagtccagaataaaaatgatcttacatgtaaagaaattaaagaattgatg
tacgatgtttctaaagaagatcacagcaagaggagcagttttgtttgtgtgcttctgagc
catggtgacgaaggaataatctatggaacagatggccctattgacctgaaaatactgaca
ggttatttcaaaggggaaaactgtagaagtctaaccggaaaacccaagcttttcattatt
caggcttgccgaggtacagatctggactctggtattgagactgacagtggtactgatgat
gacatggcatgtcacaaaataccagttgaagcagacttcttgtatgcatactctacagcg
cctggttactactcctggcgaaattcaaaggatgggtcctggttcatccagtcactttgt
gcaatgctgaaactgtacgctcacaaacttgaactcatgcacattcttactcgggttaac
caaaaggtagcgagagaatatgagtccttttccttgaactccacttttcatgcaaagaag
cagattccatgtattgtgtccatgctcacaaaagaactgtatttttatcattaa
DBGET
integrated database retrieval system